Difference between revisions of "Team:Northeastern Boston"

Line 125: Line 125:
 
  </a>
 
  </a>
 
  <p class='triad__words'>
 
  <p class='triad__words'>
−
  Humans need a quicker method for producing antibodies. Learn about our project
+
  Humans need a quicker method for producing antibodies. Learn about our project.
 
  </p>
 
  </p>
 
  </div>
 
  </div>
Line 163: Line 163:
 
<div class='big-picture__box'>
 
<div class='big-picture__box'>
 
<p class='big-picture__p'>
 
<p class='big-picture__p'>
−
The primary benefit of microalgae for antibodies is their rapid and cheap scale-up. We envision kgs worth of antibody being produced by microalgae in raceway ponds for rapid and inexpensive availability.
+
The primary benefit of microalgae for antibodies is their quick and cheap scale-up. We envision kgs worth of antibody being produced by microalgae in raceway ponds for rapid and inexpensive availability.
 
<p>
 
<p>
 
</div>
 
</div>

Revision as of 03:43, 19 September 2015

NORTHEASTERN

"Dr. George D. Yancopoulos, chief scientific officer of Regeneron, said the crisis had pointed up shortcomings in biodefense. 'Nobody is really prepared,' he said. 'Nobody in the world has rapid response capabilities.'"

- New York Times, January 2015

Standardizing Protein from Algae

Project

Humans need a quicker method for producing antibodies. Learn about our project.

Human Practices

Meetups, talks, collaboration, and some investigation of what synbio really means.

Interlab

Three promoters, one fluorescent protein. We compared expression.

The primary benefit of microalgae for antibodies is their quick and cheap scale-up. We envision kgs worth of antibody being produced by microalgae in raceway ponds for rapid and inexpensive availability.